Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:hydroxy monocarboxylic acid anion
go back to main search page
Accession:CHEBI:36059 term browser browse the term
Definition:Any monocarboxylic acid anion carrying at least one hydroxy substituent.
Synonyms:related_synonym: hydroxy monocarboxylic acid anions;   hydroxymonocarboxylic acid anion;   hydroxymonocarboxylic acid anions
 cyclic_relationship: is_conjugate_base_of CHEBI:35868


show annotations for term's descendants           Sort by:
 
3,4-dihydroxybenzoate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G EPAS1 endothelial PAS domain protein 1 increases expression
multiple interactions
ISO 3,4-dihydroxybenzoate results in increased expression of EPAS1 mRNA
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of EPAS1 mRNA
CTD PMID:19679656 NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha increases expression
affects localization
multiple interactions
ISO 3,4-dihydroxybenzoate results in increased expression of HIF1A mRNA
3,4-dihydroxybenzoate affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolite] affects the localization of HIF1A protein
[3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HIF1A mRNA
CTD PMID:19679656 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions
increases expression
ISO [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 mRNA; [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of HMOX1 protein
3,4-dihydroxybenzoate results in increased expression of HMOX1 mRNA; 3,4-dihydroxybenzoate results in increased expression of HMOX1 protein
CTD PMID:19679656 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G SLC40A1 solute carrier family 40 member 1 multiple interactions ISO 3,4-dihydroxybenzoate inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of SLC40A1 protein] CTD PMID:19679656 NCBI chr 2:189,560,590...189,580,811
Ensembl chr 2:189,560,590...189,583,758
JBrowse link
G SOD2 superoxide dismutase 2 multiple interactions
increases expression
ISO [3,4-dihydroxybenzoate co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in increased expression of SOD2 protein
3,4-dihydroxybenzoate results in increased expression of SOD2 protein
CTD PMID:19679656 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
physostigmine salicylate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Cartwright blood group) decreases activity ISO physostigmine salicylate results in decreased activity of ACHE protein CTD PMID:623676 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
pitavastatin(1-) term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA1 ATP binding cassette subfamily A member 1 multiple interactions
increases expression
ISO
EXP
GW 6471 inhibits the reaction [pitavastatin results in increased expression of ABCA1 mRNA]
pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased expression of ABCA1 protein]
GW 6471 inhibits the reaction [pitavastatin results in increased expression of ABCA1 mRNA]; PPARA protein affects the reaction [pitavastatin results in increased expression of ABCA1 mRNA]
CTD PMID:16415093 PMID:21554872 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 affects transport EXP ABCB1 protein affects the transport of pitavastatin CTD PMID:15955871 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 decreases activity
multiple interactions
EXP pitavastatin results in decreased activity of ABCB11 protein
pitavastatin inhibits the reaction [ABCB11 protein affects the import of Taurocholic Acid]; pitavastatin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
CTD PMID:15901796 PMID:24014644 NCBI chr 2:168,915,468...169,031,396
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 multiple interactions
affects transport
ISO
EXP
ABCC2 protein binds to and results in increased uptake of pitavastatin analog; pitavastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]
ABCC2 protein affects the transport of pitavastatin
CTD PMID:15955871 PMID:23562342 NCBI chr10:99,782,602...99,853,741
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) affects transport ISO
EXP
ABCG2 protein affects the transport of pitavastatin CTD PMID:15955871 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA] CTD PMID:18323514 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,218...34,257,203
JBrowse link
G FOXO1 forkhead box O1 decreases phosphorylation ISO pitavastatin results in decreased phosphorylation of FOXO1 protein CTD PMID:33034787 NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
JBrowse link
G IFNB1 interferon beta 1 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IFNB1 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of IFNB1 mRNA] CTD PMID:18323514 NCBI chr 9:21,077,104...21,077,942
Ensembl chr 9:21,077,104...21,077,942
JBrowse link
G IL6 interleukin 6 multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of IL6 mRNA] CTD PMID:18323514 NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G IRF3 interferon regulatory factor 3 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IRF3 protein]; pitavastatin inhibits the reaction [Palmitic Acid results in increased phosphorylation of IRF3 protein] CTD PMID:18323514 NCBI chr19:49,659,572...49,665,857
Ensembl chr19:49,659,569...49,665,875
JBrowse link
G IRF4 interferon regulatory factor 4 decreases expression ISO pitavastatin results in decreased expression of IRF4 protein CTD PMID:33034787 NCBI chr 6:391,752...411,443
Ensembl chr 6:391,752...411,443
JBrowse link
G LEP leptin multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of CCL2 mRNA]; pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of IL6 mRNA]; pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of TNF mRNA] CTD PMID:18323514 NCBI chr 7:128,241,201...128,257,629
Ensembl chr 7:128,241,278...128,257,629
JBrowse link
G MSTN myostatin increases expression ISO pitavastatin results in increased expression of MSTN protein CTD PMID:33034787 NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
JBrowse link
G NOS2 nitric oxide synthase 2 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; pitavastatin inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA]; pitavastatin inhibits the reaction [Poly I-C results in increased expression of NOS2 mRNA] CTD PMID:18323514 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NR1H2 nuclear receptor subfamily 1 group H member 2 multiple interactions ISO NR1H2 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of Cholesterol]]; NR1H2 gene mutant form inhibits the reaction [pitavastatin results in decreased export of Cholesterol] CTD PMID:16415093 NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 multiple interactions ISO NR1H3 gene mutant form inhibits the reaction [pitavastatin inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-AMP results in increased export of Cholesterol]]; NR1H3 gene mutant form inhibits the reaction [pitavastatin results in decreased export of Cholesterol] CTD PMID:16415093 NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
JBrowse link
G PON1 paraoxonase 1 multiple interactions
increases expression
EXP farnesyl pyrophosphate inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; Mevalonic Acid inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA]; Plicamycin inhibits the reaction [pitavastatin results in increased expression of PON1 mRNA] CTD PMID:15690306 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha multiple interactions
increases expression
EXP pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]; PPARA protein affects the reaction [pitavastatin results in increased expression of ABCA1 mRNA]
pitavastatin results in increased expression of PPARA mRNA
CTD PMID:11779144 PMID:21554872 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,756
JBrowse link
G PPARD peroxisome proliferator activated receptor delta increases expression EXP pitavastatin results in increased expression of PPARD mRNA CTD PMID:21554872 NCBI chr 6:35,342,558...35,428,180
Ensembl chr 6:35,342,558...35,428,191
JBrowse link
G RXRA retinoid X receptor alpha multiple interactions EXP pitavastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]] CTD PMID:11779144 NCBI chr 9:134,326,455...134,440,585
Ensembl chr 9:134,317,098...134,440,585
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 affects transport
increases import
multiple interactions
EXP SLCO1B1 protein affects the transport of pitavastatin
SLCO1B1 protein results in increased import of pitavastatin
Chloroquine inhibits the reaction [SLCO1B1 protein results in increased import of pitavastatin]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to pitavastatin]; SLCO1B1 protein results in increased uptake of and results in increased susceptibility to pitavastatin
CTD PMID:15955871 PMID:23564645 PMID:26750564 NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
JBrowse link
G STAT1 signal transducer and activator of transcription 1 multiple interactions ISO pitavastatin inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein] CTD PMID:18323514 NCBI chr 2:190,968,989...191,014,197
Ensembl chr 2:190,908,460...191,020,960
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO pitavastatin inhibits the reaction [LEP gene mutant form results in increased expression of TNF mRNA]; pitavastatin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] CTD PMID:18323514 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
rosuvastatin calcium term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCA1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions
EXP Rosuvastatin Calcium results in decreased expression of ABCA1 mRNA
Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of ABCA1 mRNA]
CTD PMID:18192897 NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 multiple interactions EXP
ISO
Rosuvastatin Calcium inhibits the reaction [ABCB11 protein affects the import of Taurocholic Acid]
[Cyclosporine results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium; [Glyburide results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium; [troglitazone results in decreased activity of ABCB11 protein] which results in decreased secretion of Rosuvastatin Calcium
CTD PMID:15901796 PMID:19853032 NCBI chr 2:168,915,468...169,031,396
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 multiple interactions
increases expression
affects secretion
EXP
ISO
ABCC2 protein binds to and results in increased uptake of Rosuvastatin Calcium analog; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]
Rosuvastatin Calcium results in increased expression of ABCC2 protein
[Benzbromarone results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; [Probenecid results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; [Sulfasalazine results in decreased activity of ABCC2 protein] which results in decreased secretion of Rosuvastatin Calcium; ABCC2 protein binds to and results in increased uptake of Rosuvastatin Calcium analog; Rosuvastatin Calcium analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Rosuvastatin Calcium promotes the reaction [ABCC2 protein results in increased export of 5(6)-carboxy-2',7'-dichlorofluorescein]
ABCC2 protein affects the secretion of Rosuvastatin Calcium
CTD PMID:19853032 PMID:23562342 PMID:24909372 NCBI chr10:99,782,602...99,853,741
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCC3 ATP binding cassette subfamily C member 3 increases expression ISO Rosuvastatin Calcium results in increased expression of ABCC3 protein CTD PMID:24909372 NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
JBrowse link
G ABCG1 ATP binding cassette subfamily G member 1 decreases expression EXP Rosuvastatin Calcium results in decreased expression of ABCG1 mRNA CTD PMID:18192897 NCBI chr21:42,199,689...42,304,387
Ensembl chr21:42,199,689...42,297,244
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (Junior blood group) multiple interactions
increases activity
ISO
EXP
[Novobiocin results in decreased activity of ABCG2 protein] which results in decreased secretion of Rosuvastatin Calcium
Rosuvastatin Calcium results in increased activity of ABCG2 protein
CTD PMID:19853032 PMID:30083819 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G AKT1 AKT serine/threonine kinase 1 affects phosphorylation ISO Rosuvastatin Calcium affects the phosphorylation of AKT1 protein CTD PMID:27815113 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G APOA1 apolipoprotein A1 multiple interactions
increases expression
EXP Niacin promotes the reaction [Rosuvastatin Calcium results in increased expression of APOA1 protein] CTD PMID:12767421 PMID:15539964 NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
JBrowse link
G APOB apolipoprotein B decreases expression EXP Rosuvastatin Calcium results in decreased expression of APOB protein CTD PMID:15539964 PMID:18702965 NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
JBrowse link
G BAX BCL2 associated X, apoptosis regulator multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of BAX mRNA] CTD PMID:32007421 NCBI chr19:48,954,825...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression EXP Rosuvastatin Calcium results in decreased expression of BCL2 protein CTD PMID:20852871 NCBI chr18:63,123,346...63,320,280
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G C3 complement C3 decreases expression ISO Rosuvastatin Calcium results in decreased expression of C3 mRNA CTD PMID:32771489 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G CASP3 caspase 3 increases activity
increases expression
EXP
ISO
Rosuvastatin Calcium results in increased activity of CASP3 protein
Rosuvastatin Calcium results in increased expression of CASP3 protein
CTD PMID:21478229 PMID:32771489 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
JBrowse link
G CAT catalase increases activity
multiple interactions
ISO Rosuvastatin Calcium results in increased activity of CAT protein
[Rosuvastatin Calcium co-treated with Isoproterenol] inhibits the reaction [Interleukin-6 results in increased expression of CAT protein]; Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]
CTD PMID:20146376 PMID:32007421 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCL2 C-C motif chemokine ligand 2 decreases expression ISO Rosuvastatin Calcium results in decreased expression of CCL2 mRNA CTD PMID:15681303 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,218...34,257,203
JBrowse link
G CREB5 cAMP responsive element binding protein 5 decreases expression EXP Rosuvastatin Calcium results in decreased expression of CREB5 mRNA CTD PMID:18192897 NCBI chr 7:28,299,321...28,825,894
Ensembl chr 7:28,299,321...28,825,894
JBrowse link
G CRP C-reactive protein multiple interactions EXP Rosuvastatin Calcium inhibits the reaction [CRP protein results in decreased expression of NOS3] CTD PMID:21562509 NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
JBrowse link
G CYBA cytochrome b-245 alpha chain multiple interactions
decreases expression
ISO [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 NCBI chr16:88,643,289...88,651,079
Ensembl chr16:88,643,289...88,651,054
JBrowse link
G CYBB cytochrome b-245 beta chain multiple interactions
decreases expression
ISO Rosuvastatin Calcium inhibits the reaction [Nitroglycerin results in increased expression of CYBB mRNA]
[[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species
CTD PMID:16633368 PMID:21562509 NCBI chr  X:37,780,059...37,813,461
Ensembl chr  X:37,780,059...37,813,461
JBrowse link
G ESR1 estrogen receptor 1 decreases expression ISO Rosuvastatin Calcium results in decreased expression of ESR1 protein CTD PMID:32771489 NCBI chr 6:151,654,148...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression
multiple interactions
EXP Rosuvastatin Calcium results in increased expression of GCLC mRNA
[Tetradecanoylphorbol Acetate co-treated with Rosuvastatin Calcium] results in increased expression of GCLC mRNA
CTD PMID:18154958 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
JBrowse link
G GPR183 G protein-coupled receptor 183 multiple interactions
increases expression
EXP Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in increased expression of GPR183 mRNA] CTD PMID:18192897 NCBI chr13:99,294,273...99,307,399
Ensembl chr13:99,294,539...99,307,399
JBrowse link
G GZMK granzyme K multiple interactions
increases expression
EXP Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in increased expression of GZMK mRNA] CTD PMID:18192897 NCBI chr 5:55,024,256...55,034,570
Ensembl chr 5:55,024,256...55,034,570
JBrowse link
G HNF4A hepatocyte nuclear factor 4 alpha increases secretion ISO HNF4A protein results in increased secretion of Rosuvastatin Calcium CTD PMID:27160211 NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,700...44,434,596
JBrowse link
G IL18RAP interleukin 18 receptor accessory protein decreases expression
multiple interactions
EXP Rosuvastatin Calcium results in decreased expression of IL18RAP mRNA
Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of IL18RAP mRNA]
CTD PMID:18192897 NCBI chr 2:102,418,550...102,452,568
Ensembl chr 2:102,418,689...102,452,565
JBrowse link
G IL1B interleukin 1 beta decreases expression ISO Rosuvastatin Calcium results in decreased expression of IL1B mRNA CTD PMID:15681303 NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP Rosuvastatin Calcium results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,956...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G KCNJ15 potassium inwardly rectifying channel subfamily J member 15 decreases expression EXP Rosuvastatin Calcium results in decreased expression of KCNJ15 mRNA CTD PMID:18192897 NCBI chr21:38,229,926...38,307,357
Ensembl chr21:38,155,549...38,307,357
JBrowse link
G KDR kinase insert domain receptor multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of KDR protein] CTD PMID:27097221 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G MB myoglobin affects expression ISO Rosuvastatin Calcium affects the expression of MB protein CTD PMID:27815113 NCBI chr22:35,606,764...35,623,354
Ensembl chr22:35,606,764...35,637,951
JBrowse link
G MSTN myostatin increases expression ISO Rosuvastatin Calcium results in increased expression of MSTN protein CTD PMID:33034787 NCBI chr 2:190,055,700...190,062,729
Ensembl chr 2:190,055,700...190,062,729
JBrowse link
G NFE2L2 nuclear factor, erythroid 2 like 2 multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] CTD PMID:32007421 NCBI chr 2:177,230,303...177,265,131
Ensembl chr 2:177,227,595...177,392,697
JBrowse link
G NOS2 nitric oxide synthase 2 increases expression
multiple interactions
ISO Rosuvastatin Calcium results in increased expression of NOS2 mRNA
Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of NOS2 mRNA]
CTD PMID:21443142 PMID:32007421 NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
JBrowse link
G NOS3 nitric oxide synthase 3 multiple interactions
increases expression
affects response to substance
EXP
ISO
Rosuvastatin Calcium inhibits the reaction [CRP protein results in decreased expression of NOS3]; Rosuvastatin Calcium results in increased phosphorylation of and results in increased activity of NOS3 protein
Rosuvastatin Calcium results in increased expression of NOS3 mRNA
NOS3 protein affects the susceptibility to Rosuvastatin Calcium
CTD PMID:12354446 PMID:15681303 PMID:18162361 PMID:21562509 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G ORM1 orosomucoid 1 multiple interactions
decreases expression
EXP Lipopolysaccharides inhibits the reaction [Rosuvastatin Calcium results in decreased expression of ORM1 mRNA] CTD PMID:18192897 NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
JBrowse link
G PECAM1 platelet and endothelial cell adhesion molecule 1 multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PECAM1 protein] CTD PMID:27097221 NCBI chr17:64,319,415...64,413,844
Ensembl chr17:64,319,415...64,413,776
JBrowse link
G PI3 peptidase inhibitor 3 decreases expression EXP Rosuvastatin Calcium results in decreased expression of PI3 mRNA CTD PMID:18192897 NCBI chr20:45,174,902...45,176,544
Ensembl chr20:45,174,902...45,176,544
JBrowse link
G SELP selectin P decreases expression ISO Rosuvastatin Calcium results in decreased expression of SELP mRNA CTD PMID:15681303 NCBI chr 1:169,588,849...169,630,125
Ensembl chr 1:169,588,849...169,630,193
JBrowse link
G SERPINE2 serpin family E member 2 multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of SERPINE2 protein]; Rosuvastatin Calcium inhibits the reaction [[TGFB1 protein co-treated with Serotonin] results in increased secretion of SERPINE2 protein] CTD PMID:27097221 NCBI chr 2:223,975,045...224,039,286
Ensembl chr 2:223,975,045...224,039,318
JBrowse link
G SLCO1A2 solute carrier organic anion transporter family member 1A2 increases uptake
multiple interactions
decreases expression
EXP
ISO
SLCO1A2 protein results in increased uptake of Rosuvastatin Calcium
diosmetin inhibits the reaction [SLCO1A2 protein results in increased uptake of Rosuvastatin Calcium]
Rosuvastatin Calcium results in decreased expression of SLCO1A4 protein
Fusidic Acid inhibits the reaction [SLCO1A4 protein results in increased uptake of Rosuvastatin Calcium]
CTD PMID:24909372 PMID:26888941 PMID:28867436 NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 multiple interactions
increases uptake
EXP Fusidic Acid inhibits the reaction [SLCO1B1 protein results in increased uptake of Rosuvastatin Calcium]; Rifampin inhibits the reaction [SLCO1B1 protein results in increased uptake of and results in increased susceptibility to Rosuvastatin Calcium]; SLCO1B1 protein results in increased uptake of and results in increased susceptibility to Rosuvastatin Calcium CTD PMID:23564645 PMID:26888941 PMID:31299240 NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
JBrowse link
G SLCO1B3 solute carrier organic anion transporter family member 1B3 multiple interactions
increases uptake
EXP
ISO
Fusidic Acid inhibits the reaction [SLCO1B3 protein results in increased uptake of Rosuvastatin Calcium]
Fusidic Acid inhibits the reaction [SLCO1B2 protein results in increased uptake of Rosuvastatin Calcium]
CTD PMID:26888941 PMID:31299240 NCBI chr12:20,810,705...20,916,911
Ensembl chr12:20,810,702...20,916,911
JBrowse link
G SLCO2B1 solute carrier organic anion transporter family member 2B1 multiple interactions
increases uptake
EXP Rutin promotes the reaction [SLCO2B1 protein results in increased uptake of Rosuvastatin Calcium] CTD PMID:24285294 NCBI chr11:75,151,107...75,206,549
Ensembl chr11:75,100,563...75,206,549
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions
increases expression
ISO [[[Rosuvastatin Calcium results in decreased expression of CYBB] co-treated with [Rosuvastatin Calcium results in decreased expression of CYBA]] co-treated with [Rosuvastatin Calcium results in increased expression of SOD1]] results in decreased abundance of Reactive Oxygen Species CTD PMID:21562509 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G TFF1 trefoil factor 1 decreases expression ISO Rosuvastatin Calcium results in decreased expression of TFF1 mRNA CTD PMID:32771489 NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions
decreases expression
ISO Rosuvastatin Calcium inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of TGFB1 protein]; Rosuvastatin Calcium inhibits the reaction [[TGFB1 protein co-treated with Serotonin] results in increased secretion of SERPINE2 protein]
Rosuvastatin Calcium results in decreased expression of TGFB1 mRNA
CTD PMID:15681303 PMID:27097221 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TNF tumor necrosis factor decreases expression
multiple interactions
ISO Rosuvastatin Calcium results in decreased expression of TNF mRNA
Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNF protein]
CTD PMID:15681303 PMID:32007421 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNNI3 troponin I3, cardiac type multiple interactions ISO Rosuvastatin Calcium inhibits the reaction [Isoproterenol results in increased expression of TNNI3 protein] CTD PMID:32007421 NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
JBrowse link
G VNN3P vanin 3, pseudogene decreases expression EXP Rosuvastatin Calcium results in decreased expression of VNN3 mRNA CTD PMID:18192897 NCBI chr 6:132,722,787...132,734,765
Ensembl chr 6:132,722,787...132,736,935
JBrowse link
G WT1 WT1 transcription factor increases expression ISO Rosuvastatin Calcium results in increased expression of WT1 mRNA CTD PMID:21443142 NCBI chr11:32,387,775...32,435,539
Ensembl chr11:32,387,775...32,435,564
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 24830
    chemical entity 24800
      molecular entity 24764
        ion 17255
          anion 16115
            organic anion 3182
              carboxylic acid anion 2473
                monocarboxylic acid anion 1570
                  hydroxy monocarboxylic acid anion 70
                    (+)-8'-hydroxyabscisate 0
                    (-)-ureidoglycolate 0
                    (1R,6S)-1,6-dihydroxy-4-methylcyclohexa-2,4-diene-1-carboxylate 0
                    (1S,3R,4S)-3,4-dihydroxycyclohexane-1-carboxylate 0
                    (1S,4S)-4-hydroxy-3-oxocyclohexane-1-carboxylate 0
                    (2,6-dihydroxyphenyl)acetate 0
                    (2E,4E)-3,8,8,8-tetrachloro-7-(4-chlorophenyl)-2-hydroxy-6-oxo-octa-2,4-dienoate 0
                    (2E,4E)-6-(2-aminophenyl)-2-hydroxy-6-oxohexa-2,4-dienoate 0
                    (2E,4Z)-2-hydroxy-6-oxoocta-2,4,7-trienoate 0
                    (2E,4Z)-2-hydroxy-7-methyl-6-oxo-2,4-octadienoate 0
                    (2R)-2-hydroxy monocarboxylic acid anion + 0
                    (2R)-2-hydroxy-4-(methylsulfanyl)butanoate 0
                    (2R)-4-(dimethylsulfaniumyl)-2-hydroxybutanoate 0
                    (2R,3R)-2,3-dihydroxy-3-methylpentanoate 0
                    (2R,3S)-2-alkyl-3-hydroxyalkanoate 0
                    (2S)-2-hydroxy monocarboxylic acid anion + 0
                    (2S)-2-hydroxy-2-methyl-3-oxobutanoate 0
                    (2S,3S)-2,3-dihydroxy-2,3-dihydrobenzoate 0
                    (2Z,4Z)-3,8,8-trichloro-7-(4-chlorophenyl)-2-hydroxy-6-oxoocta-2,4,7-trienoate 0
                    (3,4-dihydroxyphenyl)acetate 0
                    (3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoate 0
                    (3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoate 0
                    (3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoate 0
                    (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylate 0
                    (4E,6E)-3-hydroxydeca-4,6-dienoate 0
                    (4S,5S)-4,5-dihydroxy-2,6-dioxohexanoate 0
                    (5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoate 0
                    (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate 0
                    (9S,10R)-10-hydroxy-9-(phosphonatooxy)octadecanoate 0
                    (9S,10S)-10-hydroxy-9-(phosphonatooxy)octadecanoate 0
                    (R)-10-hydroxyoctadecanoate 0
                    (R)-2,4-dihydroxy-3-oxobutanoate 0
                    (R)-2-hydroxy-3-methylbutyrate 0
                    (R)-2-hydroxy-3-oxo-4-(phosphonatooxy)butanoate(3-) 0
                    (R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyrate 0
                    (R)-2-hydroxy-4-methylpentanoate 0
                    (R)-2-hydroxynonanoate 0
                    (R)-3,4-dihydroxy-2-oxobutanoate 0
                    (R)-3-(5-benzyloxyindol-3-yl)lactate 0
                    (R)-3-[(R)-3-hydroxybutanoyloxy]butanoate 0
                    (R)-3-phosphonatomevalonate(3-) 0
                    (R)-4-dehydropantoate 0
                    (R)-4-phosphonatopantoate(3-) 0
                    (R)-5-phosphonatomevalonate(3-) 0
                    (R)-indole-3-lactate 0
                    (R)-pantoate 0
                    (S)-2,4-dihydroxy-3-oxobutanoate 0
                    (S)-2-acetyl-2-hydroxybutanoate 0
                    (S)-2-hydroxy-3-methylbutyrate 0
                    (S)-2-hydroxy-3-oxo-4-(phosphonatooxy)butanoate(3-) 0
                    (S)-3,4-dihydroxy-2-oxobutanoate 0
                    (S)-3-(imidazol-5-yl)lactate 0
                    (S)-3-fluorolactate 0
                    (S)-3-hydroxy-2-oxo-3-phenylpropanoate 0
                    (S)-4-hydroxy-1-pyrroline-2-carboxylate 0
                    (S,S)-9,10-dihydroxyoctadecanoate 0
                    1,4-dihydroxy-2-naphthoate 0
                    1-deoxy-11beta-hydroxypentalenate 0
                    1-hydroxy-2-naphthoate 0
                    11-hydroxyjasmonate 0
                    12,20-dioxoleukotriene B4(1-) 0
                    12-hydroxyjasmonates + 0
                    13-hydroxydocosanoate 0
                    2,3-dihydroxy-2,3-dihydrobenzoate 0
                    2,3-dihydroxy-2-methylpropanoate 0
                    2,3-dihydroxy-3-methylbutanoate + 0
                    2,3-diketogulonate 0
                    2,4-dihydroxy-5-methyl-6-oxo-2,4-hexadienoate + 0
                    2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate 0
                    2-(alpha-D-mannosyl)-3-phosphonatoglycerate(3-) 0
                    2-(beta-D-glucosyloxy)-cis-cinnamate 0
                    2-(hydroxymethyl)-4-oxobutanoate 0
                    2-O-(alpha-D-glucopyranosyl)-D-glycerate 0
                    2-O-[6-O-octanoyl-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glycerate 0
                    2-O-[alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glycerate 0
                    2-acetyllactate 0
                    2-hydroxy carboxylate + 0
                    2-hydroxy-3-methylbutyrate 0
                    2-hydroxy-3-oxopropanoate 0
                    2-hydroxy-6-(2-oxidophenyl)-6-oxo-cis,cis-hexa-2,4-dienoate(2-) 0
                    2-hydroxy-6-oxo-2,4-heptadienoate + 0
                    2-hydroxy-6-oxo-7-methylocta-2,4-dienoate 0
                    2-hydroxy-6-oxo-nona-2,4-dienoate 0
                    2-hydroxy-6-oxohexa-2,4-dienoate + 0
                    2-hydroxy-6-oxoocta-2,4-dienoate 0
                    2-hydroxyibuprofen(1-) 0
                    2-hydroxypentanoate 0
                    2-phosphonato-D-glycerate(3-) 0
                    20-hydroxy-leukotriene B4(1-) 0
                    20-oxoleukotriene B4(1-) 0
                    3,4-dihydroxymandelate 0
                    3-(3,4-dihydroxyphenyl)lactate + 0
                    3-(4-hydroxyphenyl)lactate + 0
                    3-(6-hydroxyindol-3-yl)lactate 0
                    3-(imidazol-5-yl)lactate 0
                    3-ADP-glycerate(3-) 0
                    3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1,5-dioxo-octahydroinden-4-yl]propanoate 0
                    3-[(5R,6S)-5,6-dihydroxycyclohexa-1,3-dienyl]acrylate + 0
                    3-[(5S,6R)-5,6-dihydroxycyclohexa-1,3-dienyl]acrylate + 0
                    3-dehydroquinate 0
                    3-dimethylallyl-4-hydroxymandelate 0
                    3-hydroxy-3-methyl-2-oxobutanoate 0
                    3-hydroxy-3-methyl-2-oxopentanoate + 0
                    3-hydroxy-3-methylhexanoate 0
                    3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate + 0
                    3-hydroxy-5-oxohexanoate 0
                    3-hydroxydecanoyl-3-hydroxydecanoate + 0
                    3-hydroxyhexanoate 0
                    3-hydroxyisobutyrate + 0
                    3-hydroxyisovalerate 0
                    3-hydroxyphenylacetate 0
                    3-hydroxypropionate 0
                    3-hydroxypyruvate 0
                    3-oxoisoapionate + 0
                    3-oxoisoapionate 4-phosphate(2-) + 0
                    3-phosphonato-D-glycerate(3-) 0
                    3-phosphonatoshikimate(3-) 0
                    3-sulfonatolactate(2-) + 0
                    3alpha-hydroxy-3,5-dihydro-ML-236C carboxylate 0
                    3alpha-hydroxy-3,5-dihydromonacolin L carboxylate 0
                    4-O-beta-D-glucosyl-trans-caffeate 0
                    4-O-feruloyl-D-quinate 0
                    4-O-phosphonato-D-erythronate(3-) 0
                    4-O-phosphonato-D-threonate(3-) 0
                    4-amino-3-hydroxybutanoate 0
                    4-coumaroylshikimate 0
                    4-hydroxy monocarboxylic acid anion + 0
                    4-hydroxy-1-pyrroline-2-carboxylate 0
                    4-hydroxy-2-oxopentanoate + 0
                    4a,5-dihydro-ML-236C carboxylate 0
                    5-[(E)-caffeoyl]shikimate 0
                    5-hydroxy-2,4-dioxopentanoate 0
                    5-hydroxypentanoate + 0
                    6-phosphonato-5-dehydro-2-deoxy-D-gluconate(3-) 0
                    7(S),8(S)-DiHODE(1-) 0
                    7,8-dihydro-7,8-dihydroxykynurenate 0
                    7,8-dihydroxykynurenate 0
                    9-cis-4-hydroxyretinoate 0
                    9-riburonosylhypoxanthine(1-) 0
                    D-apionate 0
                    Delta(9)-tetrahydrocannabinolate 0
                    L-threonate 0
                    ML-236A carboxylate 0
                    ML-236C carboxylate 0
                    N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonate 0
                    N-acetyl-D-muramoyl-L-alaninate + 0
                    N-adenylylanthranilate 0
                    SN-38 carboxylate 0
                    [(1S)-4-hydroxy-2,2,3-trimethylcyclopent-3-enyl]acetate 0
                    all-trans-16-hydroxyretinoate 0
                    all-trans-18-hydroxyretinoate 0
                    all-trans-4,16-dihydroxyretinoate 0
                    all-trans-4,18-dihydroxyretinoate 0
                    all-trans-4-hydroxyretinoate + 0
                    all-trans-4-oxo-16-hydroxyretinoate 0
                    all-trans-4-oxo-18-hydroxyretinoate 0
                    atrochrysone carboxylate 0
                    cannabichromenate 0
                    cerivastatin(1-) + 0
                    cis,cis-2-hydroxy-6-oxohepta-2,4-dienoate 0
                    cis-4,5-dihydroxycyclohexa-2,6-diene-1,2-dicarboxylate(2-) 0
                    cis-4-coumarate 0
                    cis-5,6-dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate 0
                    cis-caffeate 0
                    demethylsulochrin(1-) 0
                    demethylsulochrin(2-) 0
                    dihydromonacolin L carboxylate 0
                    enol-phenylpyruvate 0
                    erythronate + 0
                    glycerate + 0
                    glycolate + 0
                    hexacyclonate + 0
                    homogentisate 0
                    homovanillate 0
                    hydroxy fatty acid anion + 0
                    hydroxybenzoate + 6
                    lactate + 0
                    leukotriene B4(1-) 0
                    mandelate + 0
                    mevaldate 0
                    mevalonate + 0
                    mevinic acid anion 0
                    mevinolinate 0
                    monacolin J carboxylate 0
                    monacolin L carboxylate 0
                    mutalomycin(1-) + 0
                    o-orsellinate depsidate(1-) 0
                    pentalenate 0
                    phloretate 0
                    pitavastatin(1-) + 23
                    rifamycin B(2-) 0
                    rosuvastatin(1-) + 50
                    sch 210971(2-) 0
                    sch 210972(2-) 0
                    shikimate + 0
                    soppiline A(1-) 0
                    soppiline C(1-) 0
                    sordaricin(1-) 0
                    stipitatate(1-) 0
                    stipitatate(2-) 0
                    tetracenomycin D3(1-) 0
                    tetracenomycin D3(2-) 0
                    tetracenomycin F1(1-) 0
                    tetracenomycin F2(1-) 0
                    tetracenomycin F2(2-) 0
                    trans-4-hydroxycyclohexanecarboxylate 0
                    trans-5-O-(4-coumaroyl)-D-quinate 0
                    trans-5-O-caffeoyl-D-quinate 0
                    trans-beta-D-glucosyl-2-hydroxycinnamate 0
                    trans-caffeate + 0
                    tropate 0
                    vanillylmandelate 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 24830
    subatomic particle 24789
      composite particle 24789
        hadron 24789
          baryon 24789
            nucleon 24789
              atomic nucleus 24789
                atom 24789
                  main group element atom 24656
                    p-block element atom 24656
                      carbon group element atom 24452
                        carbon atom 24416
                          organic molecular entity 24416
                            organic ion 8792
                              organic anion 3182
                                carboxylic acid anion 2473
                                  monocarboxylic acid anion 1570
                                    hydroxy monocarboxylic acid anion 70
                                      (+)-8'-hydroxyabscisate 0
                                      (-)-ureidoglycolate 0
                                      (1R,6S)-1,6-dihydroxy-4-methylcyclohexa-2,4-diene-1-carboxylate 0
                                      (1S,3R,4S)-3,4-dihydroxycyclohexane-1-carboxylate 0
                                      (1S,4S)-4-hydroxy-3-oxocyclohexane-1-carboxylate 0
                                      (2,6-dihydroxyphenyl)acetate 0
                                      (2E,4E)-3,8,8,8-tetrachloro-7-(4-chlorophenyl)-2-hydroxy-6-oxo-octa-2,4-dienoate 0
                                      (2E,4E)-6-(2-aminophenyl)-2-hydroxy-6-oxohexa-2,4-dienoate 0
                                      (2E,4Z)-2-hydroxy-6-oxoocta-2,4,7-trienoate 0
                                      (2E,4Z)-2-hydroxy-7-methyl-6-oxo-2,4-octadienoate 0
                                      (2R)-2-hydroxy monocarboxylic acid anion + 0
                                      (2R)-2-hydroxy-4-(methylsulfanyl)butanoate 0
                                      (2R)-4-(dimethylsulfaniumyl)-2-hydroxybutanoate 0
                                      (2R,3R)-2,3-dihydroxy-3-methylpentanoate 0
                                      (2R,3S)-2-alkyl-3-hydroxyalkanoate 0
                                      (2S)-2-hydroxy monocarboxylic acid anion + 0
                                      (2S)-2-hydroxy-2-methyl-3-oxobutanoate 0
                                      (2S,3S)-2,3-dihydroxy-2,3-dihydrobenzoate 0
                                      (2Z,4Z)-3,8,8-trichloro-7-(4-chlorophenyl)-2-hydroxy-6-oxoocta-2,4,7-trienoate 0
                                      (3,4-dihydroxyphenyl)acetate 0
                                      (3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoate 0
                                      (3R)-3-\{[(3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoyl]oxy\}butanoate 0
                                      (3R)-3-\{[(3R)-3-\{[(3R)-3-hydroxybutanoyl]oxy\}butanoyl]oxy\}butanoate 0
                                      (3R,4R)-3,4-dihydroxycyclohexa-1,5-diene-1-carboxylate 0
                                      (4E,6E)-3-hydroxydeca-4,6-dienoate 0
                                      (4S,5S)-4,5-dihydroxy-2,6-dioxohexanoate 0
                                      (5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoate 0
                                      (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoate 0
                                      (9S,10R)-10-hydroxy-9-(phosphonatooxy)octadecanoate 0
                                      (9S,10S)-10-hydroxy-9-(phosphonatooxy)octadecanoate 0
                                      (R)-10-hydroxyoctadecanoate 0
                                      (R)-2,4-dihydroxy-3-oxobutanoate 0
                                      (R)-2-hydroxy-3-methylbutyrate 0
                                      (R)-2-hydroxy-3-oxo-4-(phosphonatooxy)butanoate(3-) 0
                                      (R)-2-hydroxy-4-(hydroxymethylphosphinyl)butyrate 0
                                      (R)-2-hydroxy-4-methylpentanoate 0
                                      (R)-2-hydroxynonanoate 0
                                      (R)-3,4-dihydroxy-2-oxobutanoate 0
                                      (R)-3-(5-benzyloxyindol-3-yl)lactate 0
                                      (R)-3-[(R)-3-hydroxybutanoyloxy]butanoate 0
                                      (R)-3-phosphonatomevalonate(3-) 0
                                      (R)-4-dehydropantoate 0
                                      (R)-4-phosphonatopantoate(3-) 0
                                      (R)-5-phosphonatomevalonate(3-) 0
                                      (R)-indole-3-lactate 0
                                      (R)-pantoate 0
                                      (S)-2,4-dihydroxy-3-oxobutanoate 0
                                      (S)-2-acetyl-2-hydroxybutanoate 0
                                      (S)-2-hydroxy-3-methylbutyrate 0
                                      (S)-2-hydroxy-3-oxo-4-(phosphonatooxy)butanoate(3-) 0
                                      (S)-3,4-dihydroxy-2-oxobutanoate 0
                                      (S)-3-(imidazol-5-yl)lactate 0
                                      (S)-3-fluorolactate 0
                                      (S)-3-hydroxy-2-oxo-3-phenylpropanoate 0
                                      (S)-4-hydroxy-1-pyrroline-2-carboxylate 0
                                      (S,S)-9,10-dihydroxyoctadecanoate 0
                                      1,4-dihydroxy-2-naphthoate 0
                                      1-deoxy-11beta-hydroxypentalenate 0
                                      1-hydroxy-2-naphthoate 0
                                      11-hydroxyjasmonate 0
                                      12,20-dioxoleukotriene B4(1-) 0
                                      12-hydroxyjasmonates + 0
                                      13-hydroxydocosanoate 0
                                      2,3-dihydroxy-2,3-dihydrobenzoate 0
                                      2,3-dihydroxy-2-methylpropanoate 0
                                      2,3-dihydroxy-3-methylbutanoate + 0
                                      2,3-diketogulonate 0
                                      2,4-dihydroxy-5-methyl-6-oxo-2,4-hexadienoate + 0
                                      2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate 0
                                      2-(alpha-D-mannosyl)-3-phosphonatoglycerate(3-) 0
                                      2-(beta-D-glucosyloxy)-cis-cinnamate 0
                                      2-(hydroxymethyl)-4-oxobutanoate 0
                                      2-O-(alpha-D-glucopyranosyl)-D-glycerate 0
                                      2-O-[6-O-octanoyl-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glycerate 0
                                      2-O-[alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glycerate 0
                                      2-acetyllactate 0
                                      2-hydroxy carboxylate + 0
                                      2-hydroxy-3-methylbutyrate 0
                                      2-hydroxy-3-oxopropanoate 0
                                      2-hydroxy-6-(2-oxidophenyl)-6-oxo-cis,cis-hexa-2,4-dienoate(2-) 0
                                      2-hydroxy-6-oxo-2,4-heptadienoate + 0
                                      2-hydroxy-6-oxo-7-methylocta-2,4-dienoate 0
                                      2-hydroxy-6-oxo-nona-2,4-dienoate 0
                                      2-hydroxy-6-oxohexa-2,4-dienoate + 0
                                      2-hydroxy-6-oxoocta-2,4-dienoate 0
                                      2-hydroxyibuprofen(1-) 0
                                      2-hydroxypentanoate 0
                                      2-phosphonato-D-glycerate(3-) 0
                                      20-hydroxy-leukotriene B4(1-) 0
                                      20-oxoleukotriene B4(1-) 0
                                      3,4-dihydroxymandelate 0
                                      3-(3,4-dihydroxyphenyl)lactate + 0
                                      3-(4-hydroxyphenyl)lactate + 0
                                      3-(6-hydroxyindol-3-yl)lactate 0
                                      3-(imidazol-5-yl)lactate 0
                                      3-ADP-glycerate(3-) 0
                                      3-[(3aS,4S,5R,7aS)-5-hydroxy-7a-methyl-1,5-dioxo-octahydroinden-4-yl]propanoate 0
                                      3-[(5R,6S)-5,6-dihydroxycyclohexa-1,3-dienyl]acrylate + 0
                                      3-[(5S,6R)-5,6-dihydroxycyclohexa-1,3-dienyl]acrylate + 0
                                      3-dehydroquinate 0
                                      3-dimethylallyl-4-hydroxymandelate 0
                                      3-hydroxy-3-methyl-2-oxobutanoate 0
                                      3-hydroxy-3-methyl-2-oxopentanoate + 0
                                      3-hydroxy-3-methylhexanoate 0
                                      3-hydroxy-5,9,17-trioxo-4,5:9,10-disecoandrosta-1(10),2-dien-4-oate + 0
                                      3-hydroxy-5-oxohexanoate 0
                                      3-hydroxydecanoyl-3-hydroxydecanoate + 0
                                      3-hydroxyhexanoate 0
                                      3-hydroxyisobutyrate + 0
                                      3-hydroxyisovalerate 0
                                      3-hydroxyphenylacetate 0
                                      3-hydroxypropionate 0
                                      3-hydroxypyruvate 0
                                      3-oxoisoapionate + 0
                                      3-oxoisoapionate 4-phosphate(2-) + 0
                                      3-phosphonato-D-glycerate(3-) 0
                                      3-phosphonatoshikimate(3-) 0
                                      3-sulfonatolactate(2-) + 0
                                      3alpha-hydroxy-3,5-dihydro-ML-236C carboxylate 0
                                      3alpha-hydroxy-3,5-dihydromonacolin L carboxylate 0
                                      4-O-beta-D-glucosyl-trans-caffeate 0
                                      4-O-feruloyl-D-quinate 0
                                      4-O-phosphonato-D-erythronate(3-) 0
                                      4-O-phosphonato-D-threonate(3-) 0
                                      4-amino-3-hydroxybutanoate 0
                                      4-coumaroylshikimate 0
                                      4-hydroxy monocarboxylic acid anion + 0
                                      4-hydroxy-1-pyrroline-2-carboxylate 0
                                      4-hydroxy-2-oxopentanoate + 0
                                      4a,5-dihydro-ML-236C carboxylate 0
                                      5-[(E)-caffeoyl]shikimate 0
                                      5-hydroxy-2,4-dioxopentanoate 0
                                      5-hydroxypentanoate + 0
                                      6-phosphonato-5-dehydro-2-deoxy-D-gluconate(3-) 0
                                      7(S),8(S)-DiHODE(1-) 0
                                      7,8-dihydro-7,8-dihydroxykynurenate 0
                                      7,8-dihydroxykynurenate 0
                                      9-cis-4-hydroxyretinoate 0
                                      9-riburonosylhypoxanthine(1-) 0
                                      D-apionate 0
                                      Delta(9)-tetrahydrocannabinolate 0
                                      L-threonate 0
                                      ML-236A carboxylate 0
                                      ML-236C carboxylate 0
                                      N-[(9-beta-D-ribofuranosylpurin-6-yl)carbamoyl]threonate 0
                                      N-acetyl-D-muramoyl-L-alaninate + 0
                                      N-adenylylanthranilate 0
                                      SN-38 carboxylate 0
                                      [(1S)-4-hydroxy-2,2,3-trimethylcyclopent-3-enyl]acetate 0
                                      all-trans-16-hydroxyretinoate 0
                                      all-trans-18-hydroxyretinoate 0
                                      all-trans-4,16-dihydroxyretinoate 0
                                      all-trans-4,18-dihydroxyretinoate 0
                                      all-trans-4-hydroxyretinoate + 0
                                      all-trans-4-oxo-16-hydroxyretinoate 0
                                      all-trans-4-oxo-18-hydroxyretinoate 0
                                      atrochrysone carboxylate 0
                                      cannabichromenate 0
                                      cerivastatin(1-) + 0
                                      cis,cis-2-hydroxy-6-oxohepta-2,4-dienoate 0
                                      cis-4,5-dihydroxycyclohexa-2,6-diene-1,2-dicarboxylate(2-) 0
                                      cis-4-coumarate 0
                                      cis-5,6-dihydroxy-4-isopropylcyclohexa-1,3-dienecarboxylate 0
                                      cis-caffeate 0
                                      demethylsulochrin(1-) 0
                                      demethylsulochrin(2-) 0
                                      dihydromonacolin L carboxylate 0
                                      enol-phenylpyruvate 0
                                      erythronate + 0
                                      glycerate + 0
                                      glycolate + 0
                                      hexacyclonate + 0
                                      homogentisate 0
                                      homovanillate 0
                                      hydroxy fatty acid anion + 0
                                      hydroxybenzoate + 6
                                      lactate + 0
                                      leukotriene B4(1-) 0
                                      mandelate + 0
                                      mevaldate 0
                                      mevalonate + 0
                                      mevinic acid anion 0
                                      mevinolinate 0
                                      monacolin J carboxylate 0
                                      monacolin L carboxylate 0
                                      mutalomycin(1-) + 0
                                      o-orsellinate depsidate(1-) 0
                                      pentalenate 0
                                      phloretate 0
                                      pitavastatin(1-) + 23
                                      rifamycin B(2-) 0
                                      rosuvastatin(1-) + 50
                                      sch 210971(2-) 0
                                      sch 210972(2-) 0
                                      shikimate + 0
                                      soppiline A(1-) 0
                                      soppiline C(1-) 0
                                      sordaricin(1-) 0
                                      stipitatate(1-) 0
                                      stipitatate(2-) 0
                                      tetracenomycin D3(1-) 0
                                      tetracenomycin D3(2-) 0
                                      tetracenomycin F1(1-) 0
                                      tetracenomycin F2(1-) 0
                                      tetracenomycin F2(2-) 0
                                      trans-4-hydroxycyclohexanecarboxylate 0
                                      trans-5-O-(4-coumaroyl)-D-quinate 0
                                      trans-5-O-caffeoyl-D-quinate 0
                                      trans-beta-D-glucosyl-2-hydroxycinnamate 0
                                      trans-caffeate + 0
                                      tropate 0
                                      vanillylmandelate 0
paths to the root